Body Systems

Breast Cancer3 Results found

Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Primary Breast Cancer…

This two-arm, randomized, open-label, multicenter study will evaluate the efficacy and safety of Kadcyla (trastuzumab emtansine, also known as T-DM1) in combination with Perjeta (pertuzumab) versus Herceptin (trastuzumab) in combination with Perjeta and a taxane as adjuvant therapy in patients wi

Principal Investigator 
Sasha Smiljanic
Body Locations and Systems 
Breast Cancer
Area 
North Vancouver
Age 
18 and above

Taxane Following Anthracyclines as Adjuvant Therapy in Operable HER2-Positive Breast Cancer…

This two-arm, randomized, open-label, multicenter study will evaluate the effica cy and safety of Kadcyla (trastuzumab emtansine, also known as T-DM1) in combina tion with Perjeta (pertuzumab) versus Herceptin (trastuzumab) in combination wit h Perjeta and a taxane as adjuvant therapy in patients

Principal Investigator 
Stephen Chia
Body Locations and Systems 
Breast Cancer
Area 
Vancouver
Age 
18 and above